Home
Scholarly Works
P.2.e.001 Methylene blue for residual symptoms and...
Conference

P.2.e.001 Methylene blue for residual symptoms and for cognitive dysfunction in bipolar disorder: results of a double-blind trial

Authors

Alda M; MacQueen GM; McKinnon M; Garnham J; MacLellan S; Hajek T; O'Donovan C; Sokolenko M

Volume

21

Pagination

pp. s417-s418

Publisher

Elsevier

Publication Date

September 1, 2011

DOI

10.1016/s0924-977x(11)70674-5

Conference proceedings

European Neuropsychopharmacology

ISSN

0924-977X

Contact the Experts team